Bitcoin
81319.92
-3123.46
-3.84%
Crude Oil
98.93
+1.35
+1.36%
Gold
4059.7
-86.3
-2.13%
Copper
6.38
-0.19
-2.99%
Silver
54.99
-2.87
-5.22%
Dow Jones
52856.09
+360.21
+0.68%
SP500
7656.32
-100.85
-1.32%
NASDAQ
26702.86
+278.04
+1.04%

CheckMan Stock Market Overview

Trending Stocks

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
1.7
+95.00%
Top Gainers
706,725
Top Gainers
5.16
+50.00%
Top Gainers
465,685
Top Gainers
2.84
+36.97%
Top Gainers
323,019
Top Gainers
1.32
+29.02%
Top Gainers
677,960
Top Gainers
3.86
+29.02%
Top Gainers
118,875
Top Gainers
138
+26.09%
Top Gainers
250,606
Top Gainers
14.72
+25.27%
Top Gainers
2,029,476
Top Gainers
16.93
+20.56%
Top Gainers
103,411
Top Gainers
319.8
+19.57%
Top Gainers
182,703
Top Gainers
14.595
+19.49%
Top Gainers
1,145,586
Top Gainers

Red List

Name and Ticker
Last
% Change
% Change and Signal
Volume
Signal
5.5
-94.00%
Top Loosers
604,695
Top Loosers
82700
-81.02%
Top Loosers
763,022
Top Loosers
1.735
-80.98%
Top Loosers
522,208
Top Loosers
11.1
-59.46%
Top Loosers
189,071
Top Loosers
7.88
-55.58%
Top Loosers
682,483
Top Loosers
20.96
-53.96%
Top Loosers
229,459
Top Loosers
28.56
-49.75%
Top Loosers
108,249
Top Loosers
1.32
-43.94%
Top Loosers
1,270,495
Top Loosers
72.8371
-40.24%
Top Loosers
741,775
Top Loosers
3.21
-39.56%
Top Loosers
62,219,132
Top Loosers

In Today's Headlines

Tesla: Q3 Proves The Vision Advances, But Earnings Must Catch Up (Downgrade)
12:31
22 Oct 2026
Tesla: Q3 Proves The Vision Advances, But Earnings Must Catch Up (Downgrade)

I'm downgrading Tesla, Inc., from Buy to Hold, with a reduced price target of $360 due to valuation concerns despite operational progress. Q3 2026 saw positive free cash flow, improved gross margins, and advances in FSD subscriptions, Robotaxi, Optimus production, and energy storage capacity. While TSLA's growth investments are materializing, earnings growth lags the valuation premium, with the stock trading at a 215x FWD non-GAAP P/E.

AstraZeneca Gets Accelerated FDA Nod for Ultomiris in IgA Nephropathy
12:31
22 Oct 2026
AstraZeneca Gets Accelerated FDA Nod for Ultomiris in IgA Nephropathy

AZN wins accelerated FDA approval for Ultomiris in IgA nephropathy, marking the fifth approved indication for the drug in the United States.

Chevron Eyes $1B Gulf Asset Sale to Focus on Growth Projects
12:31
22 Oct 2026
Chevron Eyes $1B Gulf Asset Sale to Focus on Growth Projects

CVX explores a potential $1 billion sale of mature U.S. Gulf oil and gas assets as it shifts focus to newer offshore projects and long-term production growth.

KB Home (KBH) Down 8.8% Since Last Earnings Report: Can It Rebound?
12:31
22 Oct 2026
KB Home (KBH) Down 8.8% Since Last Earnings Report: Can It Rebound?

KB Home (KBH) reported earnings 30 days ago. What's next for the stock?

Thor Industries (THO) Down 8.1% Since Last Earnings Report: Can It Rebound?
12:31
22 Oct 2026
Thor Industries (THO) Down 8.1% Since Last Earnings Report: Can It Rebound?

Thor Industries (THO) reported earnings 30 days ago. What's next for the stock?

AutoZone (AZO) Up 11% Since Last Earnings Report: Can It Continue?
12:31
22 Oct 2026
AutoZone (AZO) Up 11% Since Last Earnings Report: Can It Continue?

AutoZone (AZO) reported earnings 30 days ago. What's next for the stock?

Prediction: One of the World's Biggest Stocks Could Still Have Room to Run
12:30
22 Oct 2026
Prediction: One of the World's Biggest Stocks Could Still Have Room to Run

Alphabet's cloud business just posted growth that would make most tech companies blush, yet the stock sits well below its recent highs.

The Bottom Line on Dividend ETFs: Why SCHD Wins on Efficiency and Income
12:30
22 Oct 2026
The Bottom Line on Dividend ETFs: Why SCHD Wins on Efficiency and Income

Schwab U.S. Dividend Equity ETF offers a significantly lower expense ratio and higher trailing yield than ProShares - S&P 500 Dividend Aristocrats® ETF. ProShares - S&P 500 Dividend Aristocrats® ETF focuses on companies with 25-plus years of dividend growth, while Schwab U.S. Dividend Equity ETF screens for fundamental quality and cash flow.

Blue Ops Introduces B-Series Maritime Portfolio with Production-Ready B-18 and B-39 Uncrewed Surface Vessels
12:30
22 Oct 2026
Blue Ops Introduces B-Series Maritime Portfolio with Production-Ready B-18 and B-39 Uncrewed Surface Vessels

U.S.-designed and built platforms available for orders, delivering affordable, mission-ready capabilities for U.S. Navy and allied maritime operations U.S.-designed and built platforms available for orders, delivering affordable, mission-ready capabilities for U.S. Navy and allied maritime operations

BioForce Nanosciences Holdings, Inc. Expands Beyond Nevada with Texas Leasehold Portfolio and Advances Herrin-1 Feasibility Evaluation
12:30
22 Oct 2026
BioForce Nanosciences Holdings, Inc. Expands Beyond Nevada with Texas Leasehold Portfolio and Advances Herrin-1 Feasibility Evaluation

HOUSTON, Oct. 22, 2026 (GLOBE NEWSWIRE) -- BioForce Nanosciences Holdings, Inc. (OTC: BFNH) (“BFNH”) (“Company”) announces the expansion of its oil and gas asset portfolio beyond Nevada through a 100% leasehold interest in two oil and gas leases totaling approximately 67.59 acres in Liberty County, Texas. The Texas properties include: An approximately 40.19-acre lease assigned to BFNH by CELT eResources LLC ; and An approximately 27.40-acre lease entered into by BFNH with a private lessor.